Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study - PubMed (original) (raw)
Multicenter Study
doi: 10.1093/humrep/det268. Epub 2013 Jul 5.
C Decanter, S Bringer-Deutsch, N Rives, S Mirallié, J C Pech, D De Ziegler, F Carré-Pigeon, P May-Panloup, C Sifer, V Amice, T Schweitzer, G Porcu-Buisson, C Poirot; French Study Group for Ovarian and Testicular Cryopreservation (GRECOT)
Affiliations
- PMID: 23832792
- DOI: 10.1093/humrep/det268
Multicenter Study
Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study
B Courbiere et al. Hum Reprod. 2013 Sep.
Abstract
Study question: What are the outcomes of French emergency IVF procedures involving embryo freezing for fertility preservation before gonadotoxic treatment?
Summary answer: Pregnancy rates after emergency IVF, cryopreservation of embryos, storage, thawing and embryo transfer (embryo transfer), in the specific context of the preservation of female fertility, seem to be similar to those reported for infertile couples undergoing ART.
Study design, size, duration: A French retrospective multicentre cohort study initiated by the GRECOT network-the French Study Group for Ovarian and Testicular Cryopreservation. We sent an e-mail survey to the 97 French centres performing the assisted reproduction technique in 2011, asking whether the centre performed emergency IVF and requesting information about the patients' characteristics, indications, IVF cycles and laboratory and follow-up data. The response rate was 53.6% (52/97).
Participants/materials, setting, methods: Fourteen French centres reported that they performed emergency IVF (56 cycles in total) before gonadotoxic treatment, between 1999 and July 2011, in 52 patients.
Main results and the role of chance: The patients had a mean age of 28.9 ± 4.3 years, and a median length of relationship of 3 years (1 month-15 years). Emergency IVF was indicated for haematological cancer (42%), brain tumour (23%), sarcoma (3.8%), mesothelioma (n = 1) and bowel cancer (n = 1). Gynaecological problems accounted for 17% of indications. In 7.7% of cases, emergency IVF was performed for autoimmune diseases. Among the 52 patients concerned, 28% (n = 14) had undergone previous courses of chemotherapy before beginning controlled ovarian stimulation (COS). The initiation of gonadotoxic treatment had to be delayed in 34% of the patients (n = 19). In total, 56 cycles were initiated. The mean duration of stimulation was 11.2 ± 2.5 days, with a mean peak estradiol concentration on the day on which ovulation was triggered of 1640 ± 1028 pg/ml. Three cycles were cancelled due to ovarian hyperstimulation syndrome (n = 1), poor response (n = 1) and treatment error (n = 1). A mean of 8.2 ± 4.8 oocytes were retrieved, with 6.1 ± 4.2 mature oocytes and 4.4 ± 3.3 pronuclear-stage embryos per cycle. The mean number of embryos frozen per cycle was 4.2 ± 3.1. During follow-up, three patients died from the consequences of their disease. For the 49 surviving patients, 22.5% of the couples concerned (n = 11) requested embryo replacement. A total of 33 embryos were thawed with a post-thawing survival rate of 76%. Embryo replacement was finally performed for 10 couples with a total of 25 embryos transferred, leading to one biochemical pregnancy, one miscarriage and three live births. Clinical pregnancy rate and live birth per couple who wanted a pregnancy after cancer were, respectively, 36% (95% CI = 10.9-69.2%) and 27% (95% CI = 6.0-61%).
Limitations, reasons for caution: The overall response rate for clinics was 53.6%. Therefore, it is not only that patients may not have been included, but also that those that were included were biased towards the University sector with a response rate of 83% (25/30) for a small number of patients.
Wider implications of the findings: According to literature, malignant disease is a risk factor for a poor response to COS. However, patients having emergency IVF before gonadotoxic treatment have a reasonable chance of pregnancy after embryo replacement. Embryo freezing is a valuable approach that should be included among the strategies used to preserve fertility.
Study funding/competing interest(s): No external funding was sought for this study. None of the authors has any conflict of interest to declare.
Keywords: IVF; cancer; embryo freezing; fertility preservation; premature ovarian failure.
Similar articles
- Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N, Ben-David G, Ben-Yosef D, Almog B, Many A, Pauzner D, Lessing JB, Amit A, Azem F. Michaan N, et al. Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):175-7. doi: 10.1016/j.ejogrb.2009.12.023. Epub 2010 Jan 13. Eur J Obstet Gynecol Reprod Biol. 2010. PMID: 20074845 - Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM, Ramanathan P. Alvarez RM, et al. Hum Reprod. 2018 Nov 1;33(11):2051-2059. doi: 10.1093/humrep/dew158. Hum Reprod. 2018. PMID: 27370358 - Factors affecting the outcome of frozen-thawed embryo transfer.
Veleva Z, Orava M, Nuojua-Huttunen S, Tapanainen JS, Martikainen H. Veleva Z, et al. Hum Reprod. 2013 Sep;28(9):2425-31. doi: 10.1093/humrep/det251. Epub 2013 Jun 11. Hum Reprod. 2013. PMID: 23756705 - Cryopreservation of human embryos and its contribution to in vitro fertilization success rates.
Wong KM, Mastenbroek S, Repping S. Wong KM, et al. Fertil Steril. 2014 Jul;102(1):19-26. doi: 10.1016/j.fertnstert.2014.05.027. Epub 2014 Jun 2. Fertil Steril. 2014. PMID: 24890275 Review. - Clinical utility of freeze-all approach in ART treatment: A mini-review.
Sciorio R, Esteves SC. Sciorio R, et al. Cryobiology. 2020 Feb 1;92:9-14. doi: 10.1016/j.cryobiol.2019.11.041. Epub 2019 Nov 23. Cryobiology. 2020. PMID: 31770530 Review.
Cited by
- Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW, Lee S, Min KJ, Hong JH, Song JY, Lee JK, Lee NW, Kim T. Cho HW, et al. Int J Mol Sci. 2020 Oct 21;21(20):7792. doi: 10.3390/ijms21207792. Int J Mol Sci. 2020. PMID: 33096794 Free PMC article. Review. - Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois.
Luke B, Brown MB, Spector LG, Stern JE, Smith YR, Williams M, Koch L, Schymura MJ. Luke B, et al. J Assist Reprod Genet. 2016 May;33(5):667-674. doi: 10.1007/s10815-016-0669-5. Epub 2016 Feb 3. J Assist Reprod Genet. 2016. PMID: 26843393 Free PMC article. - Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
Cai H, Shen H. Cai H, et al. Braz J Med Biol Res. 2016;49(6):e5227. doi: 10.1590/1414-431X20165227. Epub 2016 May 10. Braz J Med Biol Res. 2016. PMID: 27191608 Free PMC article. - Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation.
Kim S, Lee S, Park HT, Song JY, Kim T. Kim S, et al. Genes (Basel). 2021 Sep 28;12(10):1525. doi: 10.3390/genes12101525. Genes (Basel). 2021. PMID: 34680919 Free PMC article. Review. - Fertility status perception, fertility preservation and desire to have children in cancer survivors: French VICAN survey.
Jegaden M, Bouhnik AD, Préau M, Bendiane MK, Peretti-Watel P, Mancini J, Courbiere B. Jegaden M, et al. Future Sci OA. 2018 Oct 5;4(10):FSO343. doi: 10.4155/fsoa-2018-0018. eCollection 2018 Dec. Future Sci OA. 2018. PMID: 30450230 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials